EyePoint (EYPT) Capital Expenditures (QoQ) (2010 - 2026)
EyePoint (EYPT) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.90% |
| Dec 31, 2025 | 13,208.33% |
| Sep 30, 2025 | 33.33% |
| Jun 30, 2025 | -59.09% |
| Mar 31, 2025 | -97.30% |
| Dec 31, 2024 | -25.98% |
| Sep 30, 2024 | 799.05% |
| Jun 30, 2024 | -158.88% |
| Jun 30, 2023 | -200.00% |
| Mar 31, 2023 | -17.26% |
| Dec 31, 2022 | -51.17% |
| Sep 30, 2022 | 449.54% |
| Jun 30, 2022 | 46.31% |
| Sep 30, 2021 | 424.00% |
| Dec 31, 2020 | 50.00% |
| Sep 30, 2020 | 392.31% |
| Jun 30, 2020 | 62.50% |
| Mar 31, 2020 | 166.67% |
| Jun 30, 2019 | -86.26% |
| Mar 31, 2019 | 37.88% |